Your browser doesn't support javascript.
loading
Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors.
Ergun, Yakup; Esen, Selin Akturk; Bardakci, Murat; Ucar, Gokhan; Kalkan, Ziya; Urakci, Zuhat; Seyran, Erdogan; Dogan, Mutlu; Eren, Tulay; Aslan, Volkan; Kahraman, Seda; Genc, Emine Eylem; Acikgoz, Yusuf; Dirikoc, Merve; Esen, Irfan; Uncu, Dogan.
Afiliación
  • Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey.
  • Esen SA; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Bardakci M; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Ucar G; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Kalkan Z; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
  • Urakci Z; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
  • Seyran E; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Dogan M; Department of Medical Oncology, UHS Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Eren T; Department of Medical Oncology, UHS Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
  • Aslan V; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
  • Kahraman S; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Genc EE; Department of Hematology, Batman Training and Research Hospital, Batman, Turkey.
  • Acikgoz Y; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Dirikoc M; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
  • Esen I; Department of Internal Medicine, VM Medical Park (Kecioren) Hospital, Ankara, Turkey.
  • Uncu D; Department of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
Cancer Biomark ; 34(2): 329-336, 2022.
Article en En | MEDLINE | ID: mdl-35001878
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article